ZURICH A top Swiss federal prosecutor has been cleared of wrongdoing after being suspended amid questions about his conduct during investigations into suspected corruption surrounding world soccer body FIFA, a special prosecutor in Zurich said on Friday.
ZURICH, Nov 16 A top federal Swiss prosecutor has been cleared of wrongdoing after being suspended amid questions about his conduct during investigations into suspected corruption at world soccer body FIFA, a special prosecutor in Zurich said on Friday.
ZURICH Switzerland's competition watchdog has raided the offices of financial companies, including Credit Suisse and UBS , to investigate a suspected boycott of mobile payment solutions such as Apple Pay and Samsung Pay . | Video
ZURICH Novartis launched a copy of Johnson & Johnson's (J&J) inflammation-fighting Remicade in Germany on Thursday as the Swiss drugmaker aims to catch rival biosimilars that are already available in Europe's largest healthcare market.
ZURICH Swiss drugmaker Novartis is "completely committed" to its $10 billion-per-year Sandoz generics business, a spokesman said on Thursday, after a newspaper reported Chief Executive Vas Narasimhan planned to split the unit off.
ZURICH Swiss drugmaker Roche said on Tuesday its Tecentriq medicine will get a speedy review by U.S. regulators in a tough-to-treat form of breast cancer, as it seeks to be the first company to have its immunotherapy win approval in this indication.
ZURICH, Nov 12 Flughafen Zuerich shares
tumbled on Monday after the Swiss airport operator said a
proposal by regulators could trim its revenue by 150 million
Swiss francs ($148.7 million) annually and jeopardise future
ZURICH, Nov 7 Swiss testing and inspection
company SGS cut its profit targets for 2020 on
Wednesday, saying a downturn in commodities markets had also
prompted it to make management changes.
* Shares down more than 2 percent
(Adds comments from investors, analysts)
ZURICH Switzerland's Roche and Novartis and other drugmakers are touting new treatments for a blindness-causing disease that hits millions of older people, as patent expiries are set to open up one of medicine's most lucrative markets.